The US Food and Drug Administration (FDA) has accepted AstraZeneca's new drug application (NDA) for naloxegol, an investigational peripherally-acting mu-opioid receptor antagonist (PAMORA). The drug has been studied in opioid-induced ...
Tags: Drug Application, FDA Approval
France-based NovAliX has entered into a fragment-based drug discovery project with Japanese biopharmaceutical firm Kyowa Hakko Kirin. The deal, which is a continuation of the alliance announced in January 2013, builds upon the positive ...
Innovation and integration resulting in greater feedstock flexibility have provided a significant competitive advantage for ExxonMobil’s chemical business, Steve Pryor, President of ExxonMobil Chemical Company, told attendees at the ...
Tags: ExxonMobil, Textile
Scientists from the medical sciences division at Penn State University have discovered that a compound in fish oil appears to target leukemia stem cells and could lead to a cure for the disease. The compound is a natural extract from EPA, ...
Polyunsaturated fatty acid (PUFA) is the technical term for a type of fat (fatty acid) with two or more (poly) double bonds (unsaturated). They exist in many different forms, varying in chain length, degree of unsaturation, and rotation ...
Johnson & Johnson (JNJ) subsidiary Janssen Biotech and Pharmacyclics (PCYC) have won approval from the US Food and Drug Administration (FDA) for their breakthrough therapy Imbruvica (ibrutinib) to treat patients with mantle cell lymphoma ...
Tags: Johnson&Johnson, MCL Patients
ARMGO Pharma has received a research grant from the Kennedy's Disease Association (KDA) to support preclinical work on new, orally available compounds that have potential as a novel treatment for Kennedy's Disease (KD) also known as spinal ...
Tags: Kennedy's Disease, ARMGO Pharma
Canadian biopharmaceutical firm Aeterna Zentaris has submitted a new drug application (NDA) to the US Food and Drug Administration (FDA) for its ghrelin agonist, macimorelin acetate (AEZS-130), a novel orally-active small molecule. The ...
Tags: Aeterna Zentaris, Medicine
Time is slowly running out for bulky television sets, boxy neon signs and the square-edged backlit displays we all know from shops and airports. It won’t be long before families gathering together to watch television at home will be ...
Tags: Solar Cells, Printer, Organic Lights
Synta Pharmaceuticals has announced the publication of the company's first patent application covering its proprietary Hsp90-inhibitor drug conjugate (HDC) platform, which leverages the company's expertise in chaperone biology and medicinal ...
Pulmatrix has released positive results from initial stage of Phase IB clinical trial of a bronchodilator therapy PUR0200 for patients with chronic obstructive pulmonary disease (COPD). The company said PUR0200 is the first small molecule ...
Alzheon announced the launch of the company, the securing of initial private financing, and the signing of an exclusive license agreement to a novel clinical drug candidate for Alzheimer’s disease, a family of analogs, and a drug ...
Tags: Alzheon, Alzheimer's Disease
Elevance Renewable Sciences, Inc., a high-growth specialty chemicals company, announced that it has authorized the next significant stage of its second world-scale biorefinery in Natchez, Miss., in order to expand production of its Inherent ...
Tags: Natchez Biorefinery, Chemicals
Huntsman International LLC has been granted a patent for a curable composition comprised of an epoxy resin containing on average more than one epoxy group per molecule; and as curing agent, a hybrid hardener; wherein the hybrid hardener is ...
Tags: Coating, Construction, Decoration
Elevance Renewable Sciences, Inc., a high-growth specialty chemicals company, announced that it has authorized the next significant stage of its second world-scale biorefinery in Natchez, Miss., in order to expand production of its Inherent ...
Tags: Biorefinery, Elevance